Please email us at [email protected] with our item No, NDC#, UPC# or the product link if you have any quetions. We are located in Oceanside, California. Search over 110,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name. Please note, Prescription items can only be ordered by a Drug Manufacturer, Wholesaler, Hospital, Governmental Medical Facility, VA, Pharmacy, Physician, Physician Assistant, Nurse Practitioner, Dentist, Podiatrist, Optometrist, Veterinarian, Naturopath, Licensed Lab, Physical Therapist & Pharmacist in their scope of practice. No order will ship, unless you you have provided us the Medical License (and DEA Lic. in case of controlled drug) and we had verified that. Rx items can only be shipped to AZ, AR, CA, CT, DE, FL, GA, GU, HI, IL, KS, KY, LA, ME, MA, MI, NJ, NY, PA, PR, TX, TN, VA, WA, WI and WV. If you are an International Physician or Pharmacist, please contact us before ordering.


Rx Item-Phenylbutazone USP 5Kg By Letco Medical

Phenylbutazone USP 5Kg By Letco Medical Item No.Letco611066 NDC No. 62991-2160-05 62991216005 Category: Rx This Prescription Item Can Only Be Ordered By Physicians, Pharmacies, Dentists, Wholesalers, Just change the quantity and save!Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.COMPOUNDING ITEMS SPECIALIST

Rx Item-Phenylbutazone USP 5Kg By Letco Medical

$23108.00$11552.64

Item No.:RX-LETCO611066, Phenylbutazone USP 5Kg By Letco Medical Item No.Letco611066 NDC No. 62991-2160-05 62991216005 Category: Rx This Prescription Item Can Only Be Ordered By Physicians, Pharmacies, Dentists, Wholesalers, Hospitals, Government, Va, Physician Assistants, Nurse Practitioners , Podiatrists, Opticians, Optometrists, Veterinarians, Naturalists, Licensed Labs, Physical Therapists & Pharmacists In Their Scope Of Practice. UPC No.: 66101010002900

Have a question?

PHENYLBUTAZONE USP 5KG by Letco Medical Safety Data Sheet Section 1: Identification Common Name/Trade Name Phenylbutazone USP Supplier Information Letco Medical, LLC 1316 Commerce Drive NW Decatur, AL 35601 1 (800) 239-5288 +1 (734) 843-4693 IN CASE OF EMERGENCY: Chemtrec 1 (800) 424-9300 (24 hours) Product Synonym(s) Phenylbutazone. 3,5-Pyrazolidinedione, 4-butyl-1,2-diphenylRelevant Use(s) of Product Manuf acture or Compounding of Substances Section 2: Hazards Identification Classification of Substance or Mixture Acute toxicity, oral, Category 3, Serious eye damage/eye irritation, Category 2A, Reproductive toxicity, Category 2, Specif ic target organ toxicity, repeated exposure, Category 1 (cardiovascular system, gastrointestinal tract). Signal Word Danger Hazard Statement(s) H301 Toxic if swallowed H319 Causes serious eye irritation H361 Suspected of damaging f ertility or the unborn child H372 Causes damage to organs through prolonged or repeated exposure Pictogram(s) Precautionary Statement(s) P201 Obtain special instructions bef ore use. P202 Do not handle until all saf ety precautions have been read and understood. P264 Wash hands thoroughly af ter handling. P280 Wear protective gloves/protective clothing/eye protection/f ace protection. P301+P310+P330 IF SWALLOWED Immediately call a POISON CENTER or doctor/physician. Rinse mouth. P305+P351+P338 IF IN EYES Rinse cautiously with water f or several minutes. Remove contact lenses if present and easy to do. continue rinsing. P308+P313 IF exposed or concerned Get medical advice/attention. P337+P313 If eye irritation persists Get medical advice/attention. P405 Store locked up. P501 Dispose of contents/container to an approved waste disposal plant. Hazards Not Otherwise Classified Not classif ied. Ingredient(s) with Unknown Toxicity No data available. Section 3: Composition/Information on Ingredients Chemical Name 3,5-Pyrazolidinedione, 4-butyl-1,2-diphenylCommon Name Phenylbutazone CAS Number 50-33-9 Impurities and/or Stabilizing Additives No data available Page 1 of 5 Section 4: First Aid Measures General Advice Remove from exposure. Remove contaminated clothing. For treatment advice, seek guidance from an occupational health physician or other licensed health-care provider f amiliar with workplace chemical exposures. In the United States, the national poison control center phone number is 1-800-222-1222. If person is not breathing, give artif icial respiration. If breathing is dif f icult, give oxygen if available. Persons developing serious hypersensitivity (anaphylactic) reactions must receive immediate medical attention. If Inhaled If breathing is dif f icult, remove to fresh air and keep at rest in a position comf ortable f or breathing. Call a physician if symptoms develop or persist. In Case of Skin Contact Rinse skin with water/shower. Get medical attention if irritation develops and persists. In Case of Eye Contact Rinse with water. Get medical attention if irritation develops and persists. If Swallowed Rinse mouth. If ingestion of a large amount does occur, call a poison control center immediately. Most Important Symptoms and Effects Treatment of nonsteroidal anti-inf lammatory drug (NSAID) overdose should be symptomatic and supportive and may include the f ollowing: Induce vomiting (DO NOT use syrup of ipecac) or perf orm gastric lavage. Administer activated charcoal as a slurry. For gastrointestinal hemorrhage, monitor stool guaiac and administer antacids or sucralf ate. For mild/moderate allergic reactions, administer antihistamines with or without inhaled beta agonists, corticosteroids, or epinephrine. For severe allergic reactions, administer oxygen, antihistamines, epinephrine, or corticosteroids. Nephritis or nephrotic syndrome, thrombocytopenia, or hemolytic anemia may respond to glucocorticoid administration. For severe acidosis, administer sodium bicarbonate. Administer as required: plasma volume expanders f or severe hypotension; diazepam or other benzodiazepine f or convulsions; vitamin K1 f or hypoprothrombinemia; and/or dopamine plus dobutamine intravenously to prevent or reverse early indications of renal f ailure. Forced diuresis, alkalinization or urine, and hemoperf usion may not be usef ul. (Poisindex) (USP DI) Section 5: Fire Fighting Measures Suitable Extinguishing Media Use f ire-extinguishing media appropriate f or surrounding materials. Water. Foam. Dry chemical or CO2. Special Hazards Arising From the Substance/Mixture No unusual f ire or explosion hazards noted. Special PPE and/or Precautions for Firefighters Wear suitable protective equipment. Use water spray to cool unopened containers. As with all f ires, evacuate personnel to a saf e area. Firef ighters should use self-contained breathing equipment and protective clothing. Use standard f iref ighting procedures and consider the hazards of other involved materials. Section 6: Accidental Release Measures Personal Precautions, Protective Equipment and Emergency Procedures Keep unnecessary personnel away. Do not touch damaged containers or spilled material unless wearing appropriate protective clothing. Ensure adequate ventilation. Avoid inhalation of dust from the spilled material. Wear appropriate personal protective equipment Methods and Materials Used for Containment Sweep up or vacuum up spillage and collect in suitable container f or disposal. Avoid the generation of dusts during clean-up. For waste disposal, see section 13 of the SDS. Clean surf ace thoroughly to remove residual contamination. Cleanup Procedures Sweep up or vacuum up spillage and collect in suitable container f or disposal. Avoid the generation of dusts during clean-up. For waste disposal, see section 13 of the SDS. Clean surf ace thoroughly to remove residual contamination. Section 7: Handling and Storage Precautions for Safe Handling Avoid all contact and inhalation of dust, mists, and/or vapors associated with the material. Clean equipment and work surf aces with suitable detergent or solvent af ter use. Af ter removing gloves, wash hands and other exposed skin thoroughly. Conditions for Safe Storage Store in tight container as def ined in the USP-NF. This material should be handled and stored per label instructions to ensure product integrity Page 2 of 5 Section 8: Exposure Controls/Personal Protection Components with Workplace Control Parameters TWA 0.5 mg/m3 Biological limit values No biological exposure limits noted f or the ingredient(s). Appropriate Engineering Controls Airborne exposure should be controlled primarily by engineering controls such as general dilution ventilation, local exhaust ventilation, or process enclosure. Local exhaust ventilation is generally pref erred to general exhaust because it can control the contaminant at its source, preventing dispersion into the work area. An industrial hygiene survey involving air monitoring may be used to determine the ef f ectiveness of engineering controls. Ef f ectiveness of engineering controls intended f or use with highly potent materials should be assessed by use of nontoxic surrogate materials. Local exhaust ventilation such as a laboratory f ume hood or other vented enclosure is recommended, particularly f or grinding, crushing, weighing, or other dust-generating procedures. Handle in accordance with good industrial hygiene and saf ety practice. PPE - Eye/Face Protection Saf ety glasses with sideshields are recommended. Face shields or goggles may be required if splash potential exists or if corrosive materials are present. Approved eye protection (e.g., bearing the ANSI Z87 or CSA stamp) is pref erred. Maintain eyewash f acilities in the work area. PPE - Skin Protection Chemically compatible gloves. For handling solutions, ensure that the glove material is protective against the solvent being used. Use handling practices that minimize direct hand contact. Employees who are sensitive to natural rubber (latex) should use nitrile or other synthetic nonlatex gloves. Use of powdered latex gloves should be avoided due to the risk of latex allergy. PPE - Body Protection For handling of laboratory scale quantities, a cloth lab coat is recommended. Where signif icant quantities are handled, work clothing may be necessary to prevent take-home contamination. PPE - Respiratory Protection Where respirators are deemed necessary to reduce or control occupational exposures, use NIOSH-approved respiratory protection and have an ef f ective respirator program in place (applicable U.S. regulation OSHA 29 CFR 1910.134). Section 9: Physical and Chemical Properties Appearance White to of f-white crystalline powder. Physical state: Solid. Form: Powder. Upper/Lower Flammability or Explosive Limits Flammability limit - lower (%) 30 % Flammability limit - upper (%) Not available. Explosive limit - lower (%) Not available. Explosive limit - upper (%) Not available. Odor Odorless or slight odor. Vapor Pressure < 0.0000001 kPa at 25 �C Odor Threshold Not available. Vapor Density Not available. pH 6.3 (2.8% solution) Relative Density Not available Melting Point/Freezing Point 219.2 - 224.6 �F (104 - 107 �C) Solubility Very slightly soluble in water. Solubility (other) Freely soluble in acetone, in ether, and in benzene; soluble in alcohol, in chlorof orm, and in ethyl acetate. Initial Boiling Point and Boiling Range Not available. Flash Point Not available. Evaporation Rate Not available. Flammability (Solid, Gas) Not applicable. Partition Coefficient 5 3.16 Auto-Ignition Temperature 788 �F (420 �C) (BAM, f luidized dust) Decomposition Temperature Not available. Viscosity Not available. Section 10: Stability and Reactivity Reactivity No reactivity hazards known. Chemical Stability Material is stable under normal conditions. Possibility of Hazardous Reactions No dangerous reaction known under conditions of normal use. Conditions to Avoid None known. Incompatible Materials Oxidizing agents. Strong acids. Strong bases. Hazardous Decomposition Products NOx. Irritating and/or toxic f umes or gases. Emits toxic f umes under f ire conditions. Page 3 of 5 Section 11: Toxicological Information Acute Toxicity - LD50 Oral LD50 Mouse Oral 238 mg/kg Rat 245 mg/kg Acute Toxicity - Inhalation No data available Acute Toxicity - Dermal No data available Acute Toxicity - Eye No data available. Skin Corrosion/Irritation Due to lack of data the classif ication is not possible. Serious Eye Damage/Irritation Causes serious eye irritation. 100 mg Irritancy test (Draize) Result: Irritant. Species: Rabbit Organ: Eye. Respiratory or Skin Sensitazation Due to lack of data the classif ication is not possible. Germ Cell Mutagenicity Based on available data, the classif ication criteria are not met. Mutagenicity Chromosomal aberrations in Chinese hamster ovary cells Result: Positive (with activation). Chromosomal aberrations in bone marrow cells Result: Negative. Mutagenicity Mouse dominant lethal test Result: Negative. S. typhimurium Ames assay Result: Negative. Sister chromatid exchange in Chinese hamster ovary cells Result: Negative. Carcinogenicity IARC Based on available data, the classif ication criteria are not met. IARC: Group 3; this material is not classif iable as to its carcinogenicity in humans. This material is not considered to be a carcinogen by IARC, NTP, or OSHA. Carcinogenicity ACGIH No data available Carcinogenicity NTP This material is not considered to be a carcinogen by IARC, NTP, or OSHA. Carcinogenicity OSHA This material is not considered to be a carcinogen by IARC, NTP, or OSHA. Reproductive Toxicity Suspected of damaging f ertility or the unborn child. Therapeutic use of nonsteroidal anti-inf lammatory agents (NSAIDs) during the second half of pregnancy is associated with adverse ef f ects in the f etus such as premature closure of the ductus arteriosus, which may lead to persistent pulmonary hypertension in the newborn. Animal studies have shown that NSAIDs administered during late pregnancy can cause prolonged gestation, dif f icult labor, delayed birth, and decreased pup survival rates. Reproductivity 50 mg/kg/day Reproductivity study Result: No evidence of birth def ects. Species: Rabbit >= 42 mg/kg/day Reproductivity study Result: No evidence of birth def ects. Species: Rat Specific Target Organ Toxicity - Single Exposure Due to lack of data the classif ication is not possible. Specific Target Organ Toxicity - Repeated Exposure Causes damage to organs (cardiovascular system, gastrointestinal tract) through prolonged or repeated exposure. Aspiration Hazard Based on available data, the classif ication criteria are not met. Section 12: Ecological Information Toxicity No ecotoxicity data noted f or the ingredient(s). Persistence and Degradability No data is available on the degradability of this product. Bio-accumulative Potential Not available. Mobility in Soil Not available. Other Adverse Effects Not available. Section 13: Disposal Considerations Waste Treatment Methods Product Dispose in accordance with all applicable regulations. Under RCRA, it is the responsibility of the user of the product to determine, at the time of disposal, whether the product meets RCRA criteria f or hazardous waste Waste Treatment Methods Packaging Dispose of in accordance with local regulations. Empty containers or liners may retain some product residues. This material and its container must be disposed of in a saf e manner (see: Disposal instructions). Empty containers should be taken to an approved waste handling site f or recycling or disposal. Since emptied containers may retain product residue, f ollow label warnings even af ter container is emptied. Special Precautions Landfill or Incinerations No data available Other Information No data available Section 14: Transport Information UN Number UN2811 UN Proper Shipping Name Toxic solid, organic, n.o.s. (Phenylbutazone) Transport Hazard Class(es) 6.1 Packaging Group III Environmental Hazards No data available Page 4 of 5 Section 15: Regulatory Information US f ederal regulations CERCLA/SARA Hazardous Substances - Not applicable. All components are on the U.S. EPA TSCA Inventory List. Superf und Amendments and Reauthorization Act of 1986 (SARA) Hazard categories Immediate Hazard - Yes Delayed Hazard - No Fire Hazard - No Pressure Hazard - No Reactivity Hazard - No SARA 302 Extremely hazardous substance No SARA 311/312 Hazardous chemical No Other f ederal regulations Saf e Drinking Water Act (SDWA) Not regulated. Food and Drug Administration (FDA) Not regulated. US state regulations Calif ornia Saf e Drinking Water and Toxic Enf orcement Act of 1986 (Proposition 65): This material is not known to contain any chemicals currently listed as carcinogens or reproductive toxins. International Inventories Country(s) or region Inventory name On inventory (yes/no)* Australia Australian Inventory of Chemical Substances (AICS) Yes Canada Domestic Substances List (DSL) Yes Canada Non-Domestic Substances List (NDSL) No China Inventory of Existing Chemical Substances in China (IECSC) No Europe European Inventory of Existing Commercial Chemical Yes Substances (EINECS) Europe European List of Notif ied Chemical Substances (ELINCS) No Japan Inventory of Existing and New Chemical Substances (ENCS) Yes Korea Existing Chemicals List (ECL) No New Zealand New Zealand Inventory Yes Philippines Philippine Inventory of Chemicals and Chemical Substances No (PICCS) United States & Puerto Rico Toxic Substances Control Act (TSCA) Inventory Yes *A "Yes" indicates that all components of this product comply with the inventory requirements administered by the governing country(s) Section 16: Other Information Additional Information Inf ormation on likely routes of exposure Ingestion Toxic if swallowed. Inhalation Due to lack of data the classif ication is not possible. Skin contact Due to lack of data the classif ication is not possible. Eye contact Causes serious eye irritation. Symptoms related to the physical, chemical, and toxicological characteristics Nonsteroidal anti-inf lammatory drugs: Upset stomach. Nausea. Vomiting. Diarrhea. Headache. Dizziness. Ringing in ears. Blurred vision. Nervousness. Depression. Drowsiness. Dif f iculty sleeping. Ulcers. Tiredness. Irritability. Constipation. Indigestion. Delayed and immediate ef f ects of exposure Nonsteroidal anti-inf lammatory drugs: Hypertension. Coma. Respiratory depression. Gastrointestinal bleeding. Central nervous system ef f ects. Kidney impairment. Cross sensitivity Persons sensitive to aspirin or any of the other nonsteroidal anti-inf lammatory agents may be sensitive to this material also. This material may cause bronchoconstriction or anaphylaxis in aspirin-sensitive asthmatics. Medical conditions aggravated by exposure Active alcoholism. Blood disorders. Bone marrow depression. Heart disease. Liver impairment. Kidney impairment. Peptic ulcer. Thyroid problems. Porphyria. Lupus erythematosus. Polymyalgia rheumatica. Temporal arteritis. Prepared By Lisa Russell Revision Date 01/03/2019 16:00 Disclaimer Letco Medical, LLC believes that the above information is correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. If the product is used as a component in another product, this information may not be applicable. NO WARRANTY OF FITNESS FOR ANY PARTICULAR PURPOSE, WARRANTY OF MERCHANTABILITY OR ANY OTHER WARRANTY, EXPRESSED OR IMPLIED, IS MADE CONCERNING THE INFORMATION PROVIDED ABOVE. Letco Medical shall not be held liable for any loss or damage resulting from handling, storage, use or from contact with the above product. Page 5 of 5

Phenylbutazone USP 5Kg By Letco Medical Item No.Letco611066 NDC No. 62991-2160-05 62991216005 Category: Rx This Prescription Item Can Only Be Ordered By Physicians, Pharmacies, Dentists, Wholesalers,
PHENYLBUTAZONE USP 5KG by Letco Medical
Phenylbutazone USP 5Kg By Letco Medical Item No.Letco611066 NDC No. 62991-2160-05 62991216005 Category: Rx This Prescription Item Can Only Be Ordered By Physicians, Pharmacies, Dentists, Wholesalers,

Just change the quantity and save!
Buy more Save More!
Just change the quantity and save!

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

COMPOUNDING ITEMS SPECIALIST
LETCO MEDICAL
COMPOUNDING ITEMS SPECIALIST